Edition:
India

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

0.99USD
23 Aug 2019
Change (% chg)

$0.03 (+2.68%)
Prev Close
$0.97
Open
$1.00
Day's High
$1.04
Day's Low
$0.94
Volume
209,382
Avg. Vol
147,177
52-wk High
$7.26
52-wk Low
$0.91

About

Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The Company uses its chemical induction of... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $67.63
Shares Outstanding(Mil.): 46.01
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates